Andrew L. Markhard

6.9k total citations · 3 hit papers
15 papers, 5.4k citations indexed

About

Andrew L. Markhard is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Andrew L. Markhard has authored 15 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 3 papers in Cancer Research and 1 paper in Surgery. Recurrent topics in Andrew L. Markhard's work include Mitochondrial Function and Pathology (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). Andrew L. Markhard is often cited by papers focused on Mitochondrial Function and Pathology (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). Andrew L. Markhard collaborates with scholars based in United States, China and Japan. Andrew L. Markhard's co-authors include David M. Sabatini, Yasemin Sancak, Shigeyuki Nada, Liron Bar‐Peled, Roberto Zoncu, Dos D. Sarbassov, Shomit Sengupta, Peggy P. Hsu, Siraj M. Ali and Vamsi K. Mootha and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Andrew L. Markhard

14 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB

2006 2.1k citations Dos D. Sarbassov, Siraj M. Ali et al. Molecular Cell profile →
Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids

2010 1.9k citations Yasemin Sancak, Liron Bar‐Peled et al. Cell profile →
EMRE Is an Essential Component of the Mitochondrial Calcium Uniporter Complex

2013 516 citations Yasemin Sancak, Andrew L. Markhard et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew L. Markhard United States	11	4.1k	882	844	707	588	15	5.4k
Seong A. Kang United States	17	5.2k 1.3×	1.1k 1.2×	887 1.1×	646 0.9×	626 1.1×	22	6.6k
Christian C. Dibble United States	17	3.1k 0.8×	554 0.6×	627 0.7×	680 1.0×	435 0.7×	19	4.4k
Andrei V. Budanov United States	26	4.5k 1.1×	1.1k 1.3×	872 1.0×	570 0.8×	583 1.0×	42	6.1k
Thi Bui United States	9	2.9k 0.7×	1.2k 1.4×	470 0.6×	591 0.8×	381 0.6×	11	4.3k
Timothy R. Peterson United States	15	6.1k 1.5×	1.3k 1.5×	1.3k 1.5×	1.1k 1.6×	749 1.3×	17	8.1k
Natalia Shpiro United Kingdom	26	4.3k 1.0×	517 0.6×	742 0.9×	419 0.6×	755 1.3×	36	5.8k
Jeffrey P. MacKeigan United States	32	4.4k 1.1×	848 1.0×	732 0.9×	678 1.0×	707 1.2×	62	6.5k
Manel Joaquin Spain	15	2.9k 0.7×	534 0.6×	622 0.7×	771 1.1×	294 0.5×	25	3.8k
Suchithra Menon United States	14	2.8k 0.7×	676 0.8×	562 0.7×	579 0.8×	463 0.8×	20	3.9k
Hidetaka Kosako Japan	43	5.3k 1.3×	1.6k 1.8×	1.9k 2.2×	585 0.8×	467 0.8×	118	7.6k

Countries citing papers authored by Andrew L. Markhard

Since Specialization

Citations

This map shows the geographic impact of Andrew L. Markhard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew L. Markhard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew L. Markhard more than expected).

Fields of papers citing papers by Andrew L. Markhard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew L. Markhard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew L. Markhard. The network helps show where Andrew L. Markhard may publish in the future.

Co-authorship network of co-authors of Andrew L. Markhard

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew L. Markhard. A scholar is included among the top collaborators of Andrew L. Markhard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew L. Markhard. Andrew L. Markhard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Cheng, Kai, Madhura Bhave, Andrew L. Markhard, et al.. (2025). Replicon-based genome-wide CRISPR knockout screening for the identification of host factors involved in viral replication. Nature Communications. 16(1). 11028–11028.

Rogers, Robert S., Hong Wang, Timothy Durham, et al.. (2023). Hypoxia extends lifespan and neurological function in a mouse model of aging. PLoS Biology. 21(5). e3002117–e3002117. 22 indexed citations

Markhard, Andrew L., Jason G. McCoy, Tsz‐Leung To, & Vamsi K. Mootha. (2022). A genetically encoded system for oxygen generation in living cells. Proceedings of the National Academy of Sciences. 119(43). e2207955119–e2207955119. 6 indexed citations

Ganetzky, Rebecca, Andrew L. Markhard, Irene M. Yee, et al.. (2022). Congenital Hypermetabolism and Uncoupled Oxidative Phosphorylation. New England Journal of Medicine. 387(15). 1395–1403. 21 indexed citations

Goodman, Russell P., Andrew L. Markhard, Hardik Shah, et al.. (2020). Hepatic NADH reductive stress underlies common variation in metabolic traits. Nature. 583(7814). 122–126. 142 indexed citations

Jain, Isha H., Sarah E. Calvo, Andrew L. Markhard, et al.. (2020). Genetic Screen for Cell Fitness in High or Low Oxygen Highlights Mitochondrial and Lipid Metabolism. Cell. 181(3). 716–727.e11. 147 indexed citations

Markhard, Andrew L., et al.. (2020). Evolutionary divergence reveals the molecular basis of EMRE dependence of the human MCU. Life Science Alliance. 3(10). e202000718–e202000718. 8 indexed citations

Markowitz, Tovah E., et al.. (2017). Reduced dosage of the chromosome axis factor Red1 selectively disrupts the meiotic recombination checkpoint in Saccharomyces cerevisiae. PLoS Genetics. 13(7). e1006928–e1006928. 8 indexed citations

Oxenoid, Kirill, Ying Dong, Chan Cao, et al.. (2016). Architecture of the mitochondrial calcium uniporter. Nature. 533(7602). 269–273. 255 indexed citations

10.

Sancak, Yasemin, Andrew L. Markhard, Toshimori Kitami, et al.. (2013). EMRE Is an Essential Component of the Mitochondrial Calcium Uniporter Complex. Science. 342(6164). 1379–1382. 516 indexed citations breakdown →

11.

Liu, Qingsong, Seong A. Kang, Carson C. Thoreen, et al.. (2011). Development of ATP-Competitive mTOR Inhibitors. Methods in molecular biology. 821. 447–460. 37 indexed citations

12.

Liu, Qingsong, Jae Won Chang, Jinhua Wang, et al.. (2010). Discovery of 1-(4-(4-Propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one as a Highly Potent, Selective Mammalian Target of Rapamycin (mTOR) Inhibitor for the Treatment of Cancer. DSpace@MIT (Massachusetts Institute of Technology). 11 indexed citations

13.

Liu, Qingsong, Jae Won Chang, Jinhua Wang, et al.. (2010). Discovery of 1-(4-(4-Propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one as a Highly Potent, Selective Mammalian Target of Rapamycin (mTOR) Inhibitor for the Treatment of Cancer. Journal of Medicinal Chemistry. 53(19). 7146–7155. 198 indexed citations

14.

Sancak, Yasemin, Liron Bar‐Peled, Roberto Zoncu, et al.. (2010). Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids. Cell. 141(2). 290–303. 1871 indexed citations breakdown →

15.

Sarbassov, Dos D., Siraj M. Ali, Shomit Sengupta, et al.. (2006). Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB. Molecular Cell. 22(2). 159–168. 2140 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact